FindTrial
Sign In

Effect comparison and health economic evaluation of rapid and standard hepatitis B vaccination schedules in drug users in China

A randomized control field trial for comparing coverage, full three-dose coverage and efficacy between 0-1-6 months hepatitis B vaccination schedule and 0-7-21 days hepatitis B vaccination schedule in drug users in China, with health economic evaluation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022403
Enrollment
Unknown
Registered
2019-04-10
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B

Interventions

standard hepatitis B vaccination schedule:0-1-6 months hepatitis B vaccination schedule
rapid hepatitis B vaccination schedule:0-7-21 days hepatitis B vaccination schedule

Sponsors

School of Public Health, Xi’an Jiaotong University Health Science Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Drug users from methadone maintenance treatment clinics or drug rehabilitation agencies; 2. Tested negative for HBsAg, anti-HBs, and anti-HBc.

Exclusion criteria

Exclusion criteria: 1. Those who have vaccination contraindications; 2. Pregnant women; 3. Those who have not signed informed consent.

Design outcomes

Primary

MeasureTime frame
Anti-HBs response rate;vaccine coverage;full three-dose coverage;—

Secondary

MeasureTime frame
HBV infection rate;—

Countries

China

Contacts

Public ContactGuihua Zhuang

School of Public Health, Xi'an Jiaotong University Health Science Center

zhuanggh@mail.xjtu.edu.cn+86 029-82655103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026